[ad_1] Dr. Kjems succeeds Stan Bukofzer, M.D., following his retirement; Dr. Bukofzer will continue to serve as Strategic Advisor to Company SAN DIEGO–(BUSINESS WIRE)– Ocelot Bio, Inc., a clinical-stage biopharmaceutical…
[ad_1] Dr. Kjems succeeds Stan Bukofzer, M.D., following his retirement; Dr. Bukofzer will continue to serve as Strategic Advisor to Company SAN DIEGO–(BUSINESS WIRE)– Ocelot Bio, Inc., a clinical-stage biopharmaceutical…